Page 1773 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1773

Chapter 101  Natural Killer Cell–Based Therapies  1577


            end, KIR3DL2 at the telomeric end and KIR2DL4 in the middle.   and gain of function. Conversely, adoptive transfer of fully functional
            The  A  KIR  haplotype  contains  a  fixed  content  of  genes  that  also   NK cells from wild-type mice into β2-microglobulin knockout hosts
            includes  the  inhibitory  receptors  KIR2DL1,  KIR2DL3,  and   results in NK hyporesponsiveness. 9,10  Collectively, these data support
            KIR3DL1  along  with  a  single  activating  receptor  (KIR2DS4).  In   the  model  of  NK  cell  education  as  a  dynamic,  inherently  plastic
            contrast, B KIR haplotypes contain a variable number of activating   process  where  low  level,  tonic  inhibitory  signals  are  required  to
            (KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS5, KIR3DS1) and inhibi-  maintain cytotoxic capacity. It has also been demonstrated that the
            tory (KIR2DL5A/B, KIR2DL2) genes. KIR2DL2/3 and KIR3DL1/S1   cumulative strength of inhibitory receptor signaling correlates with
            are  genes  whose  alleles  determine  whether  they  define  KIR  A   functional thresholds. This model, aptly compared to a “rheostat,”
            (KIR2DL2  and  3DL1)  or  KIR  B  (KIR2DL3  or  KIR3DS1)   permits self-tolerance in the normal state and allows for enhanced
                                                                                                                   11
            haplotypes.                                           sensitivity to damage to healthy cells through class I downregulation.
              Inhibitory  KIR  recognizes  self-class  I  human  leukocyte  antigen   Importantly, it must be emphasized that not all acquisition of NK
            (HLA)  molecules  on  potential  target  cells.  This  interaction  sup-  cell function is through NK cell education. NK cells can overcome
            presses  the  NK  cell  effector  responses.  Inhibitory  KIR  recognizes   rules of NK cell education in the presence of high concentrations
            polymorphisms  of  HLA-C  and  B  in  a  biallelic  manner  (i.e.,  C1   of cytokines, in settings such as in vitro activation where exogenous
            versus C2 and Bw4 versus Bw6). KIR2DL1, KIR2DL2/KIR2DL3   cytokines are applied or during inflammatory conditions where high
            and KIR3DL1 bind HLA class I C2, C1, and Bw4 alleles, respec-  levels  of  cytokines  are  present.  In  the  mouse,  the  importance  of
            tively. These inhibitory receptor–ligand interactions are complex, as   inflammation-induced cytokine production leading to enhanced NK
            the  mere  expression  of  the  receptors  does  not  predict  the  cellular   function  is  clearly  demonstrated  by  the  ability  of  NK  cells  from
            response.  Rather,  the  affinity  of  a  given  KIR  seems  to  depend  on   β2-microglobulin  knockout  mice,  which  are  hyporesponsive  in
            allelic  polymorphisms  both  of  KIR  and  its  MHC  class  I  ligand.   vitro, to clear murine CMV. In summary, NK education determines
            In addition, the receptor–ligand binding rules are not absolute, as   the  function  of  NK  cells  at  steady  state,  but  other  factors  may
            KIR2DL2 can bind both HLA-C1 and HLA-C2 alleles. KIR also   overcome or even dominate, especially when cytokines are admin-
            binds to HLA-A alleles (A3 and A11) that contain the Bw4 epitope,   istered to patients or used to stimulate NK cells that are adoptively
            and KIR3DL2 binds some HLA-A alleles in the context of certain   transferred.
            peptides. Our understanding of the KIR system is further complicated
            by the fact that the natural ligands for activating KIR remain largely
            unknown. Although some bind MHC molecules at low affinity, it is   Natural Killer Cell Recognition of Tumors
            not known whether MHC proteins function as the natural ligands
            in  vivo.  Although  KIR2DS1  has  been  shown  to  bind  HLA-C2,   Although the antitumor efficacy of NK cells has been most evident
            KIR2DS2 does not bind HLA-C1 but recently has been shown to   for  myeloid  malignancies,  a  wide  variety  of  solid  tumors  includ-
            recognize  threonine  80  of  HLA-A11,  which  can  be  modified  by     ing  breast,  ovarian,  hepatocellular,  colon,  neuroblastoma,  Ewing
            peptide. 5                                            sarcoma, rhabdomyosarcoma, and melanoma can be sensitive to NK
                                                                  cell  lysis.  The  relative  resistance  of  some  tumors  may  be  caused
                                                                  by  a  higher  expression  of  class  I  HLA,  which  inversely  correlates
            Additional Natural Killer Cell Receptors              with  the  susceptibility  of  primary  pre–B  cell  acute  lymphoblastic
                                                                                               12
                                                                  leukemia (ALL) blasts to NK cell lysis.  Successful destruction of a
            Several other families of activating and inhibitory receptors influence   target requires coengagement of NK cell receptors by both inhibi-
            NK cell function, some of which bind HLA molecules. The NKG2   tory and activating signals. Accordingly, activating receptors such as
            family of C-type lectin receptors that heterodimerize with CD94 may   NKG2D play an important role in immune surveillance and killing
            be  either  inhibitory  (NKG2A)  or  activating  (NKG2C),  and  can   of acute myeloid leukemia (AML) stem cells. Other tumor ligands
            recognize nonclassic HLA-E. NKG2D does not heterodimerize with   that correlate with responsiveness to NK cell-mediated killing include
            CD94 and recognizes stress-induced molecules such as MHC class I   DNAM-1  on  myelodysplastic  syndrome  blasts,  CD137  ligand  on
            polypeptide-related sequence A/B (MICA and MICB) or viral-derived   AML targets, and B7-H3, which protects neuroblastoma from NK
            proteins  like  the  CMV-related  UL  binding  proteins  (ULBP1-6).   lysis. When considering therapeutic uses of NK cells and interven-
            Additional  receptors  include  the  natural  cytotoxicity  receptors   tions  such  as  the  use  of  anti-KIR  or  anti-NKG2A  antibodies  to
            NKp30, NKp46, and NKp44, DNAM-1, and Nectin-2 (CD122),   promote  tumor  lysis,  it  is  important  to  remember  that  many  NK
            2B4,  Ig-like  receptors,  and  leukocyte-associated  immunoglobulin-  cells  circulating  in  steady-state  peripheral  blood  variably  express
            like receptor-1. These activating receptors are believed to play a role   KIR  and  NKG2A. Therefore  maximum  killing  of  targets  such  as
            in communication between NK cells and dendritic cells as well as   leukemia blasts may require blockade of multiple inhibitory receptor
            determining whether an NK cell can recognize a target.  interactions.

            Natural Killer Cell Education—The Acquisition of      Innate Lymphoid Cells
            Function, Self-Tolerance, and Alloreactivity
                                                                  Until recently, NK cells were the only known lymphocyte population
            A mechanistic explanation for the phenomenon of “hybrid resistance”   that  could  be  considered  “innate  lymphoid  cells.”  However,  more
            and “missing self” is derived from the characterization of NK cell   recently, it has been appreciated that there are a variety of different
            inhibitory receptors that recognize self-MHC class I. In both instances,   innate lymphoid cell (ILC) populations, known as ILC1, ILC2, and
            because they fail to engage inhibitory receptors, target cells lacking   ILC3 cells. Similar to the T-cell paradigm, ILCs have been categorized
            self-MHC  class  I  expression  are  sensitive  to  NK-mediated  killing.   by key transcription factor expression, which drives unique cytokine
                                                                                             13
            Thus  NK  cells  detect  either  allogeneic  cells  or  disease-associated   production in response to activation.  More specifically, ILC1 cells
            downregulation/loss  of  MHC  class  I  on  virally  infected  or  tumor   (including  NK  cells)  are  characterized  by  T-bet  expression  and
               6
            cells.  The process of inhibitory receptor signaling that leads to the   produce IFN-γ in response to the monocyte-derived cytokines IL-12
            acquisition of cytotoxicity and cytokine production has been referred   and IL-18. ILC2 cells express GATA-3 and produce IL-5 and IL-13
                                            7,8
            to as “NK cell education” or “NK licensing.”  NK cells lacking both   following stimulation with IL-25 and IL-33, and ILC3 cells express
            KIR and NKG2A are hyporesponsive and cannot be educated until   the transcription factor ROR-γt and produce IL-22 in response to
            inhibitory receptors are expressed. Relevant to the field of allo-HCT,   IL-1 and IL-23 stimulation. The physiologic role for these cells, both
            NK cell education may not be fixed. For instance, adoptive transfer   in health and pathology is still emerging, but recent studies suggest
            of hypofunctional NK cells from β2-microglobulin knockout mice   that ILC1 cells play a role in anticancer responses and ILC2 and ILC3
            (that lack MHC class I) into wild-type mice leads to their education   cells may assist in response to pulmonary and intestinal pathogens
   1768   1769   1770   1771   1772   1773   1774   1775   1776   1777   1778